» Articles » PMID: 3615198

GT to AT Transition at a Splice Donor Site Causes Skipping of the Preceding Exon in Phenylketonuria

Overview
Specialty Biochemistry
Date 1987 Jul 24
PMID 3615198
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Classical Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH). We isolated several mutant PAH cDNA clones from a PKU carrier individual and showed that they contained an internal 116 base pair deletion, corresponding precisely to exon 12 of the human chromosomal PAH gene. The deletion causes the synthesis of a truncated protein lacking the C-terminal 52 amino acids. Gene transfer and expression studies using the mutant PAH cDNA indicated that the deletion abolishes PAH activity in the cell as a result of protein instability. To determine the molecular basis of the deletion, the mutant chromosomal PAH gene was isolated from this individual and shown to contain a GT-- greater than AT substitution at the 5' splice donor site of intron 12. Thus, the consequence of the splice donor site mutation in the human liver is the skipping of the preceding exon during RNA splicing.

Citing Articles

EHMT2 as a Candidate Gene for an Autosomal Recessive Neurodevelopmental Syndrome.

Carvalho L, Rzasa J, Kerkhof J, McConkey H, Fishman V, Koksharova G Mol Neurobiol. 2024; .

PMID: 39674972 DOI: 10.1007/s12035-024-04655-x.


Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.

Joynt A, Evans T, Pellicore M, Davis-Marcisak E, Aksit M, Eastman A PLoS Genet. 2020; 16(10):e1009100.

PMID: 33085659 PMC: 7605713. DOI: 10.1371/journal.pgen.1009100.


Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels.

Kanavy D, McNulty S, Jairath M, Brnich S, Bizon C, Powell B Genome Med. 2019; 11(1):77.

PMID: 31783775 PMC: 6884856. DOI: 10.1186/s13073-019-0683-1.


Personalized medicine: Genetic risk prediction of drug response.

Zhang G, Nebert D Pharmacol Ther. 2017; 175:75-90.

PMID: 28213088 PMC: 5653378. DOI: 10.1016/j.pharmthera.2017.02.036.


Clinical profile and molecular characterization of Galactosemia in Brazil: identification of seven novel mutations.

Garcia D, Camelo Jr J, Molfetta G, Turcato M, Souza C, Porta G BMC Med Genet. 2016; 17(1):39.

PMID: 27176039 PMC: 4866286. DOI: 10.1186/s12881-016-0300-8.


References
1.
Friedman P, Kaufman S, Kang E . Nature of the molecular defect in phenylketonuria and hyperphenylalaninaemia. Nature. 1972; 240(5377):157-9. DOI: 10.1038/240157a0. View

2.
DiLella A, Kwok S, Ledley F, Marvit J, Woo S . Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene. Biochemistry. 1986; 25(4):743-9. DOI: 10.1021/bi00352a001. View

3.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

4.
Maniatis T, Hardison R, Lacy E, Lauer J, OConnell C, Quon D . The isolation of structural genes from libraries of eucaryotic DNA. Cell. 1978; 15(2):687-701. DOI: 10.1016/0092-8674(78)90036-3. View

5.
Birnboim H, DOLY J . A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979; 7(6):1513-23. PMC: 342324. DOI: 10.1093/nar/7.6.1513. View